Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

L.A. McKeown

February 04, 2026

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Opinion CV Team Dispatch

April 2023 News Roundup

L.A. McKeown

April 01, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2020

Shelley Wood

December 31, 2020

News Opinion Editor's Corner

Envision Change: A Different Future for Cardiology, Medicine, Research, and Health

Shelley Wood

December 29, 2020

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

L.A. McKeown

February 11, 2020

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Todd Neale

November 14, 2017

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Industry News

First Drug-Coated Balloon (DCB) Study Results in Japan Demonstrate Consistent Clinical Outcomes with Other Medtronic DCB Studies

February 09, 2017

News Industry News

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

April 28, 2015

News Daily News

Intermittent Claudication Patients Have Better Quality of Life With Invasive Treatment

August 20, 2014

News Daily News

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

Jason Kahn

July 05, 2013

News Conference News TCT 2012

Aspirin, Cilostazol Combination Best After Angioplasty for Critical Limb Ischemia

November 01, 2012

News Conference News

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Jason Kahn

November 30, 2011

News Daily News

Small Trial Shows Promise of Cell Therapy in Critical Limb Ischemia

Jason Kahn

October 31, 2011

News Daily News

Cell Therapy Shows Promise for Limb Ischemia Due to PAD, Buerger’s Disease

Caitlin E. Cox

January 06, 2011

Advertisement

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

September 2023 News Roundup

April 2023 News Roundup

TCTMD’s Top 10 Most Popular Stories for December 2020

Envision Change: A Different Future for Cardiology, Medicine, Research, and Health

Outcome Differences Between Men and Women With PAD: EUCLID Insights

SELUTION™ First-in-Man Study Achieves Primary Endpoint

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

First Drug-Coated Balloon (DCB) Study Results in Japan Demonstrate Consistent Clinical Outcomes with Other Medtronic DCB Studies

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

Intermittent Claudication Patients Have Better Quality of Life With Invasive Treatment

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

Aspirin, Cilostazol Combination Best After Angioplasty for Critical Limb Ischemia

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Small Trial Shows Promise of Cell Therapy in Critical Limb Ischemia

Cell Therapy Shows Promise for Limb Ischemia Due to PAD, Buerger’s Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content